These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35791743)

  • 1. A new pathological perspective on thrombotic microangiopathy.
    Kim YJ
    Kidney Res Clin Pract; 2022 Sep; 41(5):524-532. PubMed ID: 35791743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review.
    McFarlane PA; Bitzan M; Broome C; Baran D; Garland J; Girard LP; Grewal K; Lapeyraque AL; Patriquin CJ; Pavenski K; Licht C
    Can J Kidney Health Dis; 2021; 8():20543581211008707. PubMed ID: 33996107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H; Matsumoto T; Yamashita Y
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinico-Histological Features of Thrombotic Microangiopathy in Renal Biopsies: A Retrospective Study.
    Manickam N; Agrawal V; Prasad P; Jain M; Prasad N
    Turk Patoloji Derg; 2022; 38(1):1-8. PubMed ID: 34514568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome.
    Shen YM
    Thromb J; 2016; 14(Suppl 1):19. PubMed ID: 27766045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.
    Hanna RM; Henriksen K; Kalantar-Zadeh K; Ferrey A; Burwick R; Jhaveri KD
    Adv Chronic Kidney Dis; 2022 Mar; 29(2):149-160.e1. PubMed ID: 35817522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab.
    Raufi AG; Scott S; Darwish O; Harley K; Kahlon K; Desai S; Lu Y; Tran MH
    Hematol Rep; 2016 Sep; 8(3):6625. PubMed ID: 27781079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The frontline of TMA management].
    Saito K; Matsumoto M
    Rinsho Ketsueki; 2022; 63(5):463-470. PubMed ID: 35662172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Hemolytic Uremic Syndrome Caused by a Rare Complement Factor B Mutation.
    Bandaru SS
    Cureus; 2022 Mar; 14(3):e23207. PubMed ID: 35317246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
    Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
    Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score.
    Addad VV; Palma LMP; Vaisbich MH; Pacheco Barbosa AM; da Rocha NC; de Almeida Cardoso MM; de Almeida JTC; de Paula de Sordi MA; Machado-Rugolo J; Arantes LF; de Andrade LGM
    Thromb J; 2023 Nov; 21(1):119. PubMed ID: 37993892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-factor H Autoantibody-Associated Hemolytic Uremic Syndrome: A Rare Entity in a Pediatric Patient.
    Singh G; Wakhare P; Sajgure AD; Bale C; Shinde N
    Cureus; 2024 May; 16(5):e60872. PubMed ID: 38910744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic microangiopathy in cancer.
    Weitz IC
    Thromb Res; 2018 Apr; 164 Suppl 1():S103-S105. PubMed ID: 29703465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].
    Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
    Rev Med Interne; 2017 Dec; 38(12):817-824. PubMed ID: 28711159
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.